20 June 2013
Keywords: biomarin, completes, ph, trial, mps, vi, drug
Article | 01 July 2002
BioMarin Pharmaceutical has reported positive results in a Phase Itrial of Aryplase (recombinant human arylsulfatase B), its
investigational treatment for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 July 2002
19 June 2013
© 2013 thepharmaletter.com